Menin-MLL inhibitor 20

CAS No. 2448173-47-3

Menin-MLL inhibitor 20( —— )

Catalog No. M28660 CAS No. 2448173-47-3

Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 125 Get Quote
10MG 205 Get Quote
25MG 417 Get Quote
50MG 617 Get Quote
100MG 878 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Menin-MLL inhibitor 20
  • Note
    Research use only, not for human use.
  • Brief Description
    Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
  • Description
    Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    γ-secretase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2448173-47-3
  • Formula Weight
    612.72
  • Molecular Formula
    C33H40N8O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (54.40 mM)
  • SMILES
    CC(C)(C)OC(N[C@H]1CN(Cc2cc(C(Nc(cc3)ccc3-c([nH]3)cc4c3ncnc4N3CCOCC3)=O)ncc2)CCC1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao B, et al. Identification of gamma-secretase inhibitor potency determinants on presenilin. J Biol Chem. 2008 Feb 1;283(5):2927-38.
molnova catalog
related products
  • BRD7-IN-1

    BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 via linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively .

  • BRD4-IN-4

    BRD4-IN-4 is a selective BRD4 inhibitor with an IC50 value of 6.83 μM for BRD4.BRD4-IN-4 selectively inhibits the proliferation of the MV4-11 cell line and arrests the cells in G1 phase.BRD4-IN-4 can be used to study MLL leukemias.

  • UNC926 hydrochloride

    UNC926 hydrochloride is a?methyl-lysine (Kme) reader domain?inhibitor.